Skip to main content
Top
Published in: Documenta Ophthalmologica 1/2015

01-08-2015 | Clinical Case Report

Rapid resolution of retinoschisis with acetazolamide

Authors: Lijuan Zhang, Roberto Reyes, Winston Lee, Ching-Lung Chen, Lawrence Chan, Tharikarn Sujirakul, Stanley Chang, Stephen H. Tsang

Published in: Documenta Ophthalmologica | Issue 1/2015

Login to get access

Abstract

Purpose

To report the results of an acetazolamide (Diamox®) treatment regimen in a genetically confirmed case of X-linked juvenile retinoschisis (XLRS).

Methods

A patient with XLRS was prescribed acetazolamide (Diamox®) at a dose of 500 mg/day, then discontinued the treatment due to non-compliance for 4 days, and finally resumed the course of treatment. Best-corrected visual acuity, retinal structure, and function were monitored with autofluorescence, spectral domain-optical coherence tomography (SD-OCT), adaptive optics scanning laser ophthalmoscopy (AOSLO), and full-field electroretinogram (ERG). Full-field ERG was performed using DTL recording electrodes and Ganzfeld stimulation according to ISCEV standards.

Results

Serial monitoring of the cysts by SD-OCT revealed a strong association between the effects of acetazolamide administration and the size of the schisis. A reduction in foveal cyst size was significant in as rapid as 6 days after acetazolamide initiation. AOSLO data revealed that the resolution of cone cell images improves as the foveal schisis decreases in size.

Conclusions

Efficacy of acetazolamide in patients with XLRS can be apparent in as rapid as a week of therapy. AOSLO can be a good method to evaluate the cone cells after acetazolamide treatment in the early stages of XLRS.
Literature
3.
go back to reference Gregori NZ, Berrocal AM, Gregori G, Murray TG, Knighton RW, Flynn HW Jr, Dubovy S, Puliafito CA, Rosenfeld PJ (2009) Macular spectral-domain optical coherence tomography in patients with X linked retinoschisis. Br J Ophthalmol 93(3):373–378. doi:10.1136/bjo.2007.136127 PubMedCrossRef Gregori NZ, Berrocal AM, Gregori G, Murray TG, Knighton RW, Flynn HW Jr, Dubovy S, Puliafito CA, Rosenfeld PJ (2009) Macular spectral-domain optical coherence tomography in patients with X linked retinoschisis. Br J Ophthalmol 93(3):373–378. doi:10.​1136/​bjo.​2007.​136127 PubMedCrossRef
5.
go back to reference Wu WW, Wong JP, Kast J, Molday RS (2005) RS1, a discoidin domain-containing retinal cell adhesion protein associated with X-linked retinoschisis, exists as a novel disulfide-linked octamer. J Biol Chem 280(11):10721–10730. doi:10.1074/jbc.M413117200 PubMedCrossRef Wu WW, Wong JP, Kast J, Molday RS (2005) RS1, a discoidin domain-containing retinal cell adhesion protein associated with X-linked retinoschisis, exists as a novel disulfide-linked octamer. J Biol Chem 280(11):10721–10730. doi:10.​1074/​jbc.​M413117200 PubMedCrossRef
6.
go back to reference Madachi-Yamamoto S, Yonemura D, Kawasaki K (1984) Diamox response of ocular standing potential as a clinical test for retinal pigment epithelium activity. Normal subjects. Nihon Ganka Gakkai Zasshi 88(10):1267–1272PubMed Madachi-Yamamoto S, Yonemura D, Kawasaki K (1984) Diamox response of ocular standing potential as a clinical test for retinal pigment epithelium activity. Normal subjects. Nihon Ganka Gakkai Zasshi 88(10):1267–1272PubMed
7.
go back to reference Kawasaki K, Mukoh S, Yonemura D, Fujii S, Segawa Y (1986) Acetazolamide-induced changes of the membrane potentials of the retinal pigment epithelial cell. Doc Ophthalmol 63(4):375–381PubMed Kawasaki K, Mukoh S, Yonemura D, Fujii S, Segawa Y (1986) Acetazolamide-induced changes of the membrane potentials of the retinal pigment epithelial cell. Doc Ophthalmol 63(4):375–381PubMed
8.
go back to reference Sternberg P Jr, Fitzke F, Finkelstein D (1982) Cyclic macular edema. Am J Ophthalmol 94(5):664–669PubMedCrossRef Sternberg P Jr, Fitzke F, Finkelstein D (1982) Cyclic macular edema. Am J Ophthalmol 94(5):664–669PubMedCrossRef
9.
go back to reference Fishman GA, Gilbert LD, Anderson RJ, Marmor MF, Weleber RG, Viana MA (1994) Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa. Ophthalmology 101(4):687–693PubMedCrossRef Fishman GA, Gilbert LD, Anderson RJ, Marmor MF, Weleber RG, Viana MA (1994) Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa. Ophthalmology 101(4):687–693PubMedCrossRef
11.
go back to reference Grover S, Fishman GA, Fiscella RG, Adelman AE (1997) Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. Retina 17(3):222–231PubMedCrossRef Grover S, Fishman GA, Fiscella RG, Adelman AE (1997) Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. Retina 17(3):222–231PubMedCrossRef
12.
go back to reference Cox SN, Hay E, Bird AC (1988) Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol 106(9):1190–1195PubMedCrossRef Cox SN, Hay E, Bird AC (1988) Treatment of chronic macular edema with acetazolamide. Arch Ophthalmol 106(9):1190–1195PubMedCrossRef
13.
go back to reference Wolfensberger TJ (1999) The role of carbonic anhydrase inhibitors in the management of macular edema. Doc Ophthalmol 97(3–4):387–397PubMedCrossRef Wolfensberger TJ (1999) The role of carbonic anhydrase inhibitors in the management of macular edema. Doc Ophthalmol 97(3–4):387–397PubMedCrossRef
15.
go back to reference Fishman GA, Glenn AM, Gilbert LD (1993) Rebound of macular edema with continued use of methazolamide in patients with retinitis pigmentosa. Arch Ophthalmol 111(12):1640–1646PubMedCrossRef Fishman GA, Glenn AM, Gilbert LD (1993) Rebound of macular edema with continued use of methazolamide in patients with retinitis pigmentosa. Arch Ophthalmol 111(12):1640–1646PubMedCrossRef
20.
21.
go back to reference Park SP, Hong IH, Tsang SH, Chang S (2013) Cellular imaging demonstrates genetic mosaicism in heterozygous carriers of an X-linked ciliopathy gene. Eur J Hum Genet 21(11):1240–1248. doi:10.1038/ejhg.2013.21 CrossRef Park SP, Hong IH, Tsang SH, Chang S (2013) Cellular imaging demonstrates genetic mosaicism in heterozygous carriers of an X-linked ciliopathy gene. Eur J Hum Genet 21(11):1240–1248. doi:10.​1038/​ejhg.​2013.​21 CrossRef
22.
go back to reference Duncan JL, Ratnam K, Birch DG, Sundquist SM, Lucero AS, Zhang Y, Meltzer M, Smaoui N, Roorda A (2011) Abnormal cone structure in foveal schisis cavities in X-linked retinoschisis from mutations in exon 6 of the RS1 gene. Invest Ophthalmol Vis Sci 52(13):9614–9623. doi:10.1167/iovs.11-8600 PubMedCentralPubMedCrossRef Duncan JL, Ratnam K, Birch DG, Sundquist SM, Lucero AS, Zhang Y, Meltzer M, Smaoui N, Roorda A (2011) Abnormal cone structure in foveal schisis cavities in X-linked retinoschisis from mutations in exon 6 of the RS1 gene. Invest Ophthalmol Vis Sci 52(13):9614–9623. doi:10.​1167/​iovs.​11-8600 PubMedCentralPubMedCrossRef
Metadata
Title
Rapid resolution of retinoschisis with acetazolamide
Authors
Lijuan Zhang
Roberto Reyes
Winston Lee
Ching-Lung Chen
Lawrence Chan
Tharikarn Sujirakul
Stanley Chang
Stephen H. Tsang
Publication date
01-08-2015
Publisher
Springer Berlin Heidelberg
Published in
Documenta Ophthalmologica / Issue 1/2015
Print ISSN: 0012-4486
Electronic ISSN: 1573-2622
DOI
https://doi.org/10.1007/s10633-015-9496-8

Other articles of this Issue 1/2015

Documenta Ophthalmologica 1/2015 Go to the issue